Vinayak Palve

493 total citations
16 papers, 313 citations indexed

About

Vinayak Palve is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Vinayak Palve has authored 16 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Vinayak Palve's work include Cell death mechanisms and regulation (4 papers), RNA Interference and Gene Delivery (3 papers) and Cancer-related gene regulation (3 papers). Vinayak Palve is often cited by papers focused on Cell death mechanisms and regulation (4 papers), RNA Interference and Gene Delivery (3 papers) and Cancer-related gene regulation (3 papers). Vinayak Palve collaborates with scholars based in India, United States and Germany. Vinayak Palve's co-authors include Tanuja Teni, Uwe Rix, Lily L. Remsing Rix, Sadhana Kannan, Binay Panda, Amritha Suresh, Moni Abraham Kuriakose, Vikram D. Kekatpure, Neeraja M. Krishnan and Fumi Kinose and has published in prestigious journals such as PLoS ONE, Nature Chemical Biology and The Journal of Pathology.

In The Last Decade

Vinayak Palve

16 papers receiving 309 citations

Peers

Countries citing papers authored by Vinayak Palve

Since Specialization

Citations

This map shows the geographic impact of Vinayak Palve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinayak Palve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinayak Palve more than expected).

Fields of papers citing papers by Vinayak Palve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinayak Palve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinayak Palve. The network helps show where Vinayak Palve may publish in the future.

Co-authorship network of co-authors of Vinayak Palve

This figure shows the co-authorship network connecting the top 25 collaborators of Vinayak Palve. A scholar is included among the top collaborators of Vinayak Palve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinayak Palve. Vinayak Palve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Discovery and design of molecular glue enhancers of CDK12–DDB1 interactions for targeted degradation of cyclin K 2024 ·RSC Chemical Biology ·(unknown), Maximilian Schmitz, (unknown), Solomon Tadesse, (unknown), (unknown), (unknown), Vinayak Palve, (unknown), K. Anand, Sylvia M. Frydman, William Roush, E. Schönbrunn, Matthias Geyer, Derek R. Duckett, Andrii Monastyrskyi	3
2	Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity 2021 ·Cancer Immunology Research ·(unknown), Zhihua Chen, Jiannong Li, Eslam Mohamed, Michael A. Davies, Inna Smalley, Derek R. Duckett, Vinayak Palve, Brian J. Czerniecki, Peter Forsyth, David Noyes, Dennis O. Adeegbe, Zeynep Eroglu, (unknown), Kenneth Y. Tsai, Uwe Rix, Christin E. Burd, Y. Ann Chen, Paulo C. Rodrı́guez, Keiran S.M. Smalley	19
3	The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors 2021 ·Cell chemical biology ·Vinayak Palve, Claire E. Knezevic, Daniel S. Bejan, Yunting Luo, Xueli Li, (unknown), Eric A. Welsh, Bin Fang, Fumi Kinose, Eric B. Haura, Álvaro N.A. Monteiro, John M. Koomen, Michael S. Cohen, Harshani R. Lawrence, Uwe Rix	25
4	Turning liabilities into opportunities: Off-target based drug repurposing in cancer 2020 ·Seminars in Cancer Biology ·Vinayak Palve, (unknown), Lily L. Remsing Rix, Uwe Rix	57
5	Functional genomics screen with pooled shRNA library and gene expression profiling with extracts of Azadirachta indica identify potential pathways for therapeutic targets in head and neck squamous cell carcinoma 2019 ·PeerJ ·Neeraja M. Krishnan, Hiroto Katoh, Vinayak Palve, (unknown), Reiko Sato, Shumpei Ishikawa, Binay Panda	2
6	Abstract B021: PARP16 is a novel target of talazoparib which contributes to synergy with adavosertib in SCLC 2019 ·Molecular Cancer Therapeutics ·Vinayak Palve, (unknown), Yunting Luo, Xueli Li, (unknown), Eric A. Welsh, Bin Fang, Fumi Kinose, Eric B. Haura, Álvaro N.A. Monteiro, John M. Koomen, Harshani R. Lawrence, Uwe Rix	1
7	Detection of High-Risk Human Papillomavirus in Oral Cavity Squamous Cell Carcinoma Using Multiple Analytes and Their Role in Patient Survival 2018 ·Journal of Global Oncology ·Vinayak Palve, (unknown), Neeraja M. Krishnan, (unknown), (unknown), Amritha Suresh, (unknown), Bonney Lee James, Vikram D. Kekatpure, Moni Abraham Kuriakose, Binay Panda	22
8	Unraveling the rewired network 2018 ·Nature Chemical Biology ·Vinayak Palve, Brent M. Kuenzi, Uwe Rix	1
9	A minimal set of internal control genes for gene expression studies in head and neck squamous cell carcinoma 2018 ·PeerJ ·Vinayak Palve, (unknown), Neeraja M. Krishnan, (unknown), Amritha Suresh, Moni Abraham Kuriakose, Binay Panda	5
10	Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells 2018 ·Molecular & Cellular Proteomics ·Claudia Ctortecka, Vinayak Palve, Brent M. Kuenzi, Bin Fang, Natália J. Sumi, Victoria Izumi, (unknown), Fumi Kinose, Lily L. Remsing Rix, Eric B. Haura, John M. Koomen, Uwe Rix	17
11	A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes 2016 ·Molecular Cancer Research ·Neeraja M. Krishnan, (unknown), (unknown), Vinayak Palve, (unknown), (unknown), Amritha Suresh, Vikram D. Kekatpure, Moni Abraham Kuriakose, Binay Panda	35
12	Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx 2015 ·Genes & Cancer ·(unknown), Prachi Jain, (unknown), Vinayak Palve, (unknown), (unknown), Vikram D. Kekatpure, Amritha Suresh, Moni Abraham Kuriakose, Binay Panda	23
13	High expression of survivin and its splice variants survivin ΔEx3 and survivin 2 B in oral cancers 2015 ·Oral Surgery Oral Medicine Oral Pathology and Oral Radiology ·(unknown), Vinayak Palve, Sadhana Kannan, (unknown), Tanuja Teni	14
14	Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers 2014 ·PLoS ONE ·Vinayak Palve, (unknown), (unknown), Sadhana Kannan, Tanuja Teni	39
15	Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells 2012 ·Radiation Oncology ·Vinayak Palve, Tanuja Teni	24
16	Human oral cancers have altered expression of Bcl‐2 family members and increased expression of the anti‐apoptotic splice variant of Mcl‐1 2008 ·The Journal of Pathology ·(unknown), (unknown), Rekha Gyanchandani, Shashi Singh Pawar, Vinayak Palve, (unknown), (unknown), Mayur Choudhary, (unknown)	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact